Unknown

Dataset Information

0

In silico analysis of natural compounds targeting structural and nonstructural proteins of chikungunya virus.


ABSTRACT: Background: Chikungunya fever presents as a high-grade fever during its acute febrile phase and can be prolonged for months as chronic arthritis in affected individuals. Currently, there are no effective drugs or vaccines against this virus. The present study was undertaken to evaluate protein-ligand interactions of all chikungunya virus (CHIKV) proteins with natural compounds from a MolBase library in order to identify potential inhibitors of CHIKV. Methods: Virtual screening of the natural compound library against four non-structural and five structural proteins of CHIKV was performed. Homology models of the viral proteins with unknown structures were created and energy minimized by molecular dynamic simulations. Molecular docking was performed to identify the potential inhibitors for CHIKV. The absorption, distribution, metabolism and excretion (ADME) toxicity parameters for the potential inhibitors were predicted for further prioritization of the compounds. Results: Our analysis predicted three compounds, Catechin-5-O-gallate, Rosmarinic acid and Arjungenin, to interact with CHIKV proteins; two (Catechin-5-O-gallate and Rosmarinic acid) with capsid protein, and one (Arjungenin) with the E3. Conclusion: The compounds identified show promise as potential antivirals, but further in vitro studies are required to test their efficacy against CHIKV.

SUBMITTER: Jain J 

PROVIDER: S-EPMC5747330 | biostudies-literature | 2017

REPOSITORIES: biostudies-literature

altmetric image

Publications

<i>In silico</i> analysis of natural compounds targeting structural and nonstructural proteins of chikungunya virus.

Jain Jaspreet J   Kumari Anchala A   Somvanshi Pallavi P   Grover Abhinav A   Pai Somnath S   Sunil Sujatha S  

F1000Research 20170830


<b>Background:</b> Chikungunya fever presents as a high-grade fever during its acute febrile phase and can be prolonged for months as chronic arthritis in affected individuals. Currently, there are no effective drugs or vaccines against this virus. The present study was undertaken to evaluate protein-ligand interactions of all chikungunya virus (CHIKV) proteins with natural compounds from a MolBase library in order to identify potential inhibitors of CHIKV. <b>Methods:</b> Virtual screening of t  ...[more]

Similar Datasets

| S-EPMC4890524 | biostudies-literature
| S-EPMC7121661 | biostudies-literature
| S-EPMC8699639 | biostudies-literature
| S-EPMC8373223 | biostudies-literature
| S-EPMC5951878 | biostudies-literature
| S-EPMC7114316 | biostudies-literature
| S-EPMC7088235 | biostudies-literature
| S-EPMC8218635 | biostudies-literature
| S-EPMC5128919 | biostudies-literature
| S-EPMC8425474 | biostudies-literature